Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alan Glicklich"'
Autor:
Jonathan Barratt, Brian Schwartz, Bess Sorensen, Margaret Macdonald, Jerlyn Tolentino, Jeannette Lo, Andrew King, Sai Prasad N Iyer, Alan Glicklich
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Immunoglobulin A nephropathy (IgAN) is the leading cause of primary glomerulonephritis worldwide with limited treatment options, especially for high-risk patients [1]. BION-1301 is a novel humanized monoclonal antibody that blocks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7eff415ea219e8776e1c0ac89b37a558
https://doi.org/10.1093/ndt/gfac067.006
https://doi.org/10.1093/ndt/gfac067.006
Autor:
Jonathan Barratt, Laura Kooienga, Billy Hour, Irfan Agha, Brian Schwartz, Bess Sorensen, Jeannette Lo, Andrew King, Taher Sathaliya, Sai Prasad N Iyer, Aaron Endsley, Alan Glicklich
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Immunoglobulin A nephropathy (IgAN) is the leading cause of primary glomerulonephritis worldwide with limited treatment options, especially for high-risk patients [1]. BION-1301 is a novel humanized monoclonal antibody that blocks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0256392901e59f872f5fd8a4e7d6e621
https://doi.org/10.1093/ndt/gfac067.011
https://doi.org/10.1093/ndt/gfac067.011
Autor:
Sung-Gyun Kim, Nam Vo, Sang-Ho Lee, Dwarakanathan Ranganathan, Lesley Inker, Mohamed El-Shahawy, Terri Spinelli, Khushboo Sheth, Todd Devries, Marianne Camargo, Andrew King, Alan Glicklich, Muh Wong
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the developed world. Up to 40% of patients with IgAN are at risk of progressing to end-stage kidney disease (ESKD), with proteinuria being a strong predictor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86bfeff33ed8f25d2175eaf404e03e1f
https://doi.org/10.1093/ndt/gfac107.004
https://doi.org/10.1093/ndt/gfac107.004
Autor:
Jeannette Lo, Jonathan Barratt, Suzanne Roy, Alan Glicklich, Cailin Sibley, Angelique Mittan, Colleen Stromatt, Aaron Endsley
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims IgA nephropathy (IgAN), the leading cause of primary glomerulonephritis, is an autoimmune disease with no approved treatments.1 Progression to end-stage-renal disease occurs in up to 45% of IgAN patients, requiring dialysis or kid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c14d45ad7ee6666251029ffdb6fc630
https://doi.org/10.1093/ndt/gfab104.0044
https://doi.org/10.1093/ndt/gfab104.0044
Autor:
Suzanne Roy, Alan Glicklich, Cailin Sibley, Jonathan Barratt, Billy Hour, Aaron Endsley, Angelique Mittan, Colleen Stromatt, Jeannette Lo
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims IgA nephropathy (IgAN), the leading cause of primary glomerulonephritis, is an autoimmune disease with no approved treatments.1 Progression to end-stage-renal disease occurs in up to 45% of IgAN patients, requiring dialysis or kid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42af3eafca78bc828b04770a0dd61003
https://doi.org/10.1093/ndt/gfab117.004
https://doi.org/10.1093/ndt/gfab117.004
Autor:
Alan Glicklich, Louis J. Aronne, Steven R. Smith, William R. Shanahan, Yuhan Li, William Soliman, Randi Fain
Publikováno v:
Postgraduate Medicine. 126:7-18
Lorcaserin, a novel selective 5-HT2C receptor agonist, is approved by the US Food and Drug Administration (FDA) for weight management in combination with lifestyle modification for adults with obesity and adults with overweight and ≥ 1 weight-relat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4b3c190f3eb4e21d9bc6ae5242d642d
https://doi.org/10.3810/pgm.2014.10.2817
https://doi.org/10.3810/pgm.2014.10.2817
Autor:
Hans-Hellmut Neumayer, Flavio Vincenti, Eduardo Mancilla-Urrea, Yves Vanrenterghem, Christian P. Larsen, Antoine Durrbach, Alan Glicklich, A. Block, Tao Duan, Philippe Lang, José Osmar Medina Pestana, Barbara A. Bresnahan, Sheila Gujrathi, Josep M. Grinyó, Josep M. Campistol
Publikováno v:
Transplantation. 91:976-983
Background. Cardiovascular disease, the most common cause of death with a functioning graft among kidney transplant recipients, can be exacerbated by immunosuppressive drugs, particularly the calcineurin inhibitors. Belatacept, a selective co-stimula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e70a02d5f6209b3d881aedab0ac9e76b
https://doi.org/10.1097/tp.0b013e31820c10eb
https://doi.org/10.1097/tp.0b013e31820c10eb
Publikováno v:
Nicotine & Tobacco Research. :ntw301
Introduction Lorcaserin is a selective serotonin 2C receptor agonist approved by the Food and Drug Administration for chronic weight management. Preclinical data suggest that it may also be effective in smoking cessation through modulation of the dop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a8b49fc0b0e73d463e8f5a79eccf4a
https://doi.org/10.1093/ntr/ntw301
https://doi.org/10.1093/ntr/ntw301